Create an Account
  1. Home
  2. Specialty
  3. Retina

VBS Fellows Foray 2020: Cases and Real-World Treatment Strategies - Part 2

VBS Fellows Foray 2020 Cases and RealWorld Treatment Strategies Part 2
Media formats available:
Details
Presenters

  • Overview

    This CME-accredited program, originally planned for the 2020 VBS Annual Meeting, is now digital! Carefully selected cases will be presented by fellows from around the globe. Retina cases you would not believe! Real-world treatment strategies will be enthusiastically discussed among the esteemed panel members. This truly unique series is designed for fellows, residents, and eye care specialists who recently entered practice and are involved in the management of patients with vitreoretinal disorders.This activity is supported by independent medical education grants from Regeneron Pharmaceuticals and Carl Zeiss Meditec.

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:
    • Discuss a wide variety of treatment approaches for both age-related macular degeneration and diabetic eye disease.
    • Develop individualized treatment plans for patients with retina disorders that use a combination of imaging, treat and extend, or treat and observe approaches.
    • Apply case study examples to real-world clinical settings.

  • Accreditation

    Provided by Evolve Medical Education

    Accreditation Statement

    Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Credit Designation Statement

    Evolve designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Participation Method

    In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

     

    Course Viewing Requirements

    Supported Browsers:

    Internet Explorer 11 for Windows

    Edge (recent versions; Chromium-based) for Windows

    Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux

    Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux

    Safari (recent versions) for Mac OSX, or iOS

    Hardware Requirements:

    4GB+ RAM

    Recommended internet speed 5Mbps+

  • Faculty and Disclosures

    DISCLOSURE POLICY
    It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.

    VIT BUCKLE SOCIETY MODERATORS:

    Anton Orlin, MD

    Associate Professor of OphthalmologyWeill Cornell Medical CollegeNew York, NY

     

    D. Wilkin Parke III, MD

    VitreoRetinal Surgery, PACo-director, Vitreoretinal Surgery Fellowship ProgramMinneapolis, MN

     

    Aleksandra V. Rachitskaya, MD

    Assistant Professor of OphthalmologyCole Eye Institute, Cleveland ClinicCleveland, OH

     

    Camila Ventura, MD, PhD

    Department of OphthalmologyRetina SpecialistDepartment of Research, DirectorAltino Ventura Foundation (FAV)Hope Eye HospitalRecife, Pernambuco, Brazil

     

    PANELISTS:

    James C. Major Jr MD, PhD, FACS

    Retina Consultants of HoustonAssistant ProfessorWeill Cornell Medical CollegeBlanton Eye InstituteHouston Methodist HospitalHouston, TX

     

    Jeremy Wolfe, MD, MS

    Associate Professor of Ophthalmology

    Oakland University William Beaumont School of MedicinePartner, Associated Retinal ConsultantsCo-Director, Vitreoretinal Fellowship ProgramRoyal Oak, MI

      FELLOWS   Sulaiman Alhumaid, MD  Bascom Palmer Eye Institute -Anne Bates Leach Eye Hospital  

     

    Samara Marafon, MD

    University of Toronto

        Nathan L. Scott, MDBascom Palmer Eye Institute     JD Wilgucki, MDUniversity of Illinois at Chicago College of Medicine   DISCLOSURE POLICY It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity. The following faculty/staff members have the following financial relationships with commercial interests:ModeratorsAnton Orlin, MD and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, and Carl Zeiss Meditec. Wilkin Parke III, MD and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Royalties: Vortex Surgical. Aleksandra V. Rachitskaya, MD and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, Allergan, and Carl Zeiss Meditec. Speaker’s Bureau: Novartis. Camila Ventura, MD, PhD has no financial relationships with commercial interests. PanelistsJames C. Major Jr MD, PhD, FACS has no financial relationships with commercial interests. Jeremy Wolfe, MD, MS and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, Allergan, Genentech, and Novartis.  Grant/Research: Genentech, Kodiak, Novartis, and Regeneron Pharmaceuticals. Speaker’s Bureau: Allergan, Genentech, Novartis, and Regeneron Pharmaceuticals. Stock/Shareholder: Vortex Surgical. FellowsSulaiman Alhumaid, MD; Samara Marafon, MD; Nathan L. Scott, MD; John Wilgucki, MD have no financial relationships with commercial interests. The Evolve staff and planners have no financial relationships with commercial interests. Nisha Mukherjee, MD, peer reviewer, have no financial relationships with commercial interests.  

  • Disclaimer

    OFF-LABEL STATEMENT This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
    DISCLAIMER The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Carl Zeiss Meditec, or Regeneron Pharmaceuticals.

  • System Requirements

    • Supported Browsers (2 most recent versions):
      • Google Chrome for Windows, Mac OS, iOS, and Android
      • Apple Safari for Mac OS and iOS
      • Mozilla Firefox for Windows, Mac OS, iOS, and Android
      • Microsoft Edge for Windows
    • Recommended Internet Speed: 5Mbps+

  • Publication Dates

    Release Date:

    Expiration Date:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

LIVE ON REACHMD RADIOBack to live radio
ReachMD Radio

Loading...

00:00
00:00
    Register

    We're glad to see you're enjoying Evolve Medical Education…
    but how about a more personalized experience?

    Register for free